• FirefoxUpgrade to the new Firefox »
  •  Dow Down0.89% Nasdaq Down0.55%

    More On P31.SI

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials


    Pharmesis International Ltd. (P31.SI)

    -SES
    0.04 0.00(0.00%) Jan 23, 12:12AM EST
    Add to Portfolio
    ProfileGet Profile for:
    Pharmesis International Ltd.
    No. 8 Yingbin Road
    Chengdu,
    China - Map
    Website: http://www.pharmesis.com

    Details 
    Index Membership:N/A
    Sector:Healthcare
    Industry:Drug Manufacturers - Major
    Full Time Employees:N/A

    Business Summary 

    Pharmesis International Ltd., an investment holding company, develops, manufactures, and sells western medicines, health tonic products, and traditional Chinese medicine (TCM) formulated products in the People’s Republic of China. The company operates through Western Drugs, TCM Formulated Drugs, and Distribution segments. It is also involved in the wholesale of chemical drugs, biological raw products, TCMs, antibiotics, and antibiotics agents. The company offers its western medicines and TCM formulated products in the form of tablets, granules, pills, etc. Its products comprise Anethole Trithione for the treatment of illness relating to the liver and gall bladder; Xiao Shi Jian Pi tablets for flatus, inappetency, dyspepsy, and spleen weakness; and Lianpu Shuangqing for the treatment of acute inflammation, such as dysentery and intestinal infection. Pharmesis International Ltd. also offers Shulinghou tablets, which clear heat and regenerate body fluid, as well as for the treatment of acute and chronic pharyngitis, laryngitis, sore throat, and hoarseness; Xiaoluotong Jiaonang for treating rheumatoid arthritis and other rheumatic diseases; and Afenka for the treatment of migrane, pain from headache, cold, nasosinusitis, muscle pain, menstrual pain, toothache, and arthritis. In addition, the company provides Er Ding granules for the treatment of jaundice and heat toxic clearance; Bear Bile and Bulbus Fritillariae oral liquid for the treatment of phlegm-heat cough; and Gansu for the treatment of acute and chronic hepatitis; and Gansu for the treatment of acute and chronic hepatitis. Pharmesis International Ltd. markets its western drugs under the Kinna brand name; and TCM formulated drugs under the Longlife brand name to approximately 2,000 hospitals through its sales and marketing personnel. The company was founded in 1996 and is headquartered in Chengdu, the People’s Republic of China.

    Key Statistics


    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Pharmesis International Ltd.

    Key Executives 
     PayExercised
    Mr. Yun Jiang , 52
    Exec. Chairman and Member of Nominating Committee
    N/AN/A
    Mr. Xuedan Wu , 52
    Chief Exec. Officer and Exec. Director
    N/AN/A
    Ms. Siaw Yean Tee , 39
    Financial Controller
    N/AN/A
    Dr. Deng Zemin ,
    Head of Research
    N/AN/A
    Ms. Siew Tian Low ACIS,
    Joint Company Sec.
    N/AN/A
    Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in SGD.